TNFSF13 antibody (AA 21-120)
Quick Overview for TNFSF13 antibody (AA 21-120) (ABIN713816)
Target
See all TNFSF13 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 21-120
-
Cross-Reactivity
- Human
-
Predicted Reactivity
- Mouse,Rat
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human TNFSF13
-
Isotype
- IgG
-
-
-
-
Application Notes
-
ELISA 1:500-1000
FCM 1:20-100
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
- TNFSF13 (Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13))
-
Alternative Name
- TNFSF13
-
Background
-
Synonyms: A proliferation inducing ligand, A proliferation-inducing ligand, APRIL, CD 256, CD256, CD256 antigen, Ligand, proliferation inducing ligand APRIL, TALL 2, TALL-2, TALL2, TNF and APOL related leukocyte expressed ligand 2, TNF related death ligand 1, TNF related death ligand, TNF- and APOL-related leukocyte expressed ligand 2, TNF-related death ligand 1, TNF13_HUMAN, TNFSF 13, TNFSF13, TNFSF13 protein, TRDL 1, TRDL-1, TRDL1, Tumor necrosis factor ligand superfamily member 13, Tumor necrosis factor ligand superfamily member 13, Tumor necrosis factor related death ligand, Tumor necrosis factor related death ligand 1, Tumor necrosis factor superfamily member 13, TWE PRIL, ZTNF2.
Background: Cytokine that binds to TNFRSF13B/TACI and to TNFRSF17/BCMA. May be implicated in the regulation of tumor cell growth. May be involved in monocyte/macrophage-mediated immunological processes.
-
Gene ID
- 8741
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response
Target
-